ONCO-Boost - HEPHAISTOS Pharma
Alternative Names: ONCO BoostLatest Information Update: 11 Mar 2024
Price :
$50 *
At a glance
- Originator HEPHAITOS PHARMA
- Class Antineoplastics; Immunotherapies
- Mechanism of Action Immunostimulants; Toll-like receptor 4 agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Solid tumours